Antifungal activity of eugenol analogues. Influence of different substituents and studies on mechanism of action

Molecules

Volumn 17, Issue 1, 2012, Pages 1002-1024

  Carrasco, Héctor ^a   Raimondi, Marcela ^b,c   Svetaz, Laura ^b   Di Liberto, Melina ^b   Rodriguez, María V ^b   Espinoza, Luis ^d   Madrid, Alejandro ^d   Zacchino, Susana ^b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^d DEPARTAMENTO DE FÍSICA   (Chile)

Author keywords

Antifungal activity; Eugenol derivatives; Lipophilicity; Mechanism of antifungal action; SAR

Indexed keywords

DRUG DERIVATIVE; ERGOSTEROL; EUGENOL; SAFROLE;

ACETYLATION; ARTHRODERMATACEAE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL MEMBRANE; CELL WALL; CHEMICAL PHENOMENA; CRYPTOCOCCUS NEOFORMANS; DRUG EFFECT; DRUG INTERACTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TINEA; TRICHOPHYTON;

ACETYLATION; ARTHRODERMATACEAE; CANDIDA ALBICANS; CANDIDIASIS; CELL MEMBRANE; CELL WALL; CRYPTOCOCCUS NEOFORMANS; DRUG INTERACTIONS; ERGOSTEROL; EUGENOL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROBIAL SENSITIVITY TESTS; SAFROLE; STRUCTURE-ACTIVITY RELATIONSHIP; TINEA; TRICHOPHYTON;

EID: 84856177805     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17011002     Document Type: Article

References (35)

1. Chen, S.; Playford, E.; Sorrel, T. Antifungal therapy in invasive fungal infections. Curr. Opin. Pharmacol. 2010, 10, 522-530.
2. Monk, B.; Goffeau, A. Outwitting multidrug resistance to antifungals. Science 2008, 321, 367-369. (Pubitemid 352035829)
3. Mathew, B.; Nath, M. Recent approaches to antifungal therapy for invasive mycoses. Chem. Med. Chem. 2009, 4, 310-323.
4. Espinel-Ingroff, A. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: A review of the literature (2005-2009). Rev. Iberoam. Micol. 2009, 26, 15-22.
5. Mukherjee, P.; Leidich, S.; Isham, N.; Leitner, I.; Ryder, N.; Ghannoum, M. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob. Agents Chemother. 2003, 47, 82-86. (Pubitemid 36070346)
6. Vicente, M.F.; Basilio, A.; Cabello, A.; Peláez, F. Microbial natural products as a source of antifungals. Clin. Microbiol. Infect. 2003, 9, 15-32. (Pubitemid 36511665)
7. Zemek, J.; Košíková, B.; Augustin, J.; Joniak, D. Antibiotic properties of lignin components. Folia Microbiol. 1979, 24, 483-486. (Pubitemid 10142856)
8. Himejima, M.; Kubo, I. Antimicrobial agents from Licaria puchuri-major and their synergistic effect to polygodial. J. Nat. Prod. 1992, 55, 620-625.
9. Kubo, I.; Muroi, H.; Himejima, M. Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids. J. Nat. Prod. 1993, 56, 220-226. (Pubitemid 23104327)
10. Fujita, K.; Kubo, I. Potentiation of fungicidal activities of trans-anethole against Saccharomyces cerevisiae under hypoxic conditions. J. Biosci. Bioeng. 2004, 98, 490-492. (Pubitemid 40144040)
11. Zacchino, S.; López, S.; Pezzenati, G.; Furlán, R.; Santecchia, C.; Muñoz, L.; Giannini, F.; Rodríguez, A.; Enriz, R. In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes. J. Nat. Prod. 1999, 62, 1353-1357. (Pubitemid 29504093)
12. Faria, T.; Ferreira, R.; Yassumoto, L.; Pinto de Souza, J.; Ishikawa, N.; de Melo Barbosa, A. Antifungal activity of essential oil isolated from Ocimum gratissimum L. (eugenol chemotype) against phytopathogenic fungi. Braz. Arch. Biol. Technol. 2006, 49, 867-871. (Pubitemid 46198227)
13. Wang, S.; Chen, P.P.; Chang, S. Antifungal activities of essential oils from indigenous cinnamon (Cinnamomum osmophloeum) leaves. Bioresour. Technol. 2005, 96, 813-818. (Pubitemid 40017784)
14. Campaniello, D.; Sinigaglia, M. Antifungal activity of eugenol against Penicillium, Aspergillus, and Fusarium species. J. Food Prot. 2010, 73, 1124-1128.
15. Cos, P.; Vlietinck, J.; Vanden Berghe, D.; Maes, L. Antiinfective potntial of natural products: How to develop a steronger in vitro proor of concept. J. Ethnopharmacol. 2006, 106, 290-302.
16. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Document M27-A3, Approved Standard, 3th ed.; Clinical and Laboratory Standards Institute (CLSI): Wayne, PA, USA, 2008. Volume 28, N 14, p. 25.
17. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Document M38-A2, Approved Standard, 2nd ed.; Clinical and Laboratory Standards Institute (CLSI): Wayne, PA, USA, 2008, Volume 28, N 16, p. 35.
18. Chami, N.; Bennis, S.; Chami, F.; Aboussekhra, A.; Remmal, A. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol. Immunol. 2005, 20, 106-111. (Pubitemid 40364735)
19. Sikemma, J.; de Bont, J.; Poolman, B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol. Rev. 1995, 59, 201-222.
20. Gill, A.; Holley, R. Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics. Int. J. Food Microbiol. 2006, 108, 1-9.
21. Voda, K.; Boh, B.; Vrtacnik, M. A quantitative structure-antifungal activity relationship study of oxygenated aromatic essential oil compounds using data structuring and PLS regression analysis. J. Mol. Model. 2004, 10, 76-84. (Pubitemid 38787179)
22. Ntamila, M.S.; Hassanali, A. Isolation of oil of clove and separation of eugenol and acetyl eugenol. J. Chem. Educ. 1976, 53, 263.
23. Carrasco Altamirano, H.; Espinoza, L.; Gallardo, C.; Cardona, W.; Catalán, K.; Russo A.; Cardile, V.; Lombardo, L.; Cuellar, M. Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (Part I). J. Braz. Chem. Soc. 2008, 19, 543-548.
24. Hidalgo, M.E.; de la Rosa, C.; Carrasco, H.; Cardona, W.; Gallardo, C.; Espinoza, L. Antioxidant capacity of eugenol derivatives. Quim. Nova 2009, 32, 1467-1470.
25. Ernst, E.; Roling, E.; Petzold, R.; Keele, D.; Klepser, M. In vitro activityof micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies. Antimicrob. Agents Chemother. 2002, 46, 3846-3853. (Pubitemid 35403260)
26. Klepser, M.; Ernst, E.; Ernst, M.; Messer, S.; Pfaller, M. Evaluation of endpoints for antifungal susceptibility determinations with LY303366. Antimicrob. Agents Chemother. 1998, 42, 1387-1391. (Pubitemid 28257637)
27. Pfaller, M.A.; Diekema, D. Epidemiology of invasive candidiasis: A persistent public health problem. Clin. Microbiol. Rev. 2007, 20, 133-163. (Pubitemid 46167771)
28. Kontoyannis, D.; Mantadakis, E.; Samonis, G. Systemic mycoses in the immunocompromised host: An update in antifungal therapy. J. Hosp. Infect. 2003, 53, 243-258. (Pubitemid 38002036)
29. Singh, N. Treatment of opportunistic mycoses: How long is long enough? Lancet Infect. Dis. 2003, 3, 703-708. (Pubitemid 37345348)
30. Weitzman, R.; Summerbell, I. The dermatophytes. Clin. Microb. Rev. 1995, 8, 240-259.
31. Frost, D.; Brandt, K.; Cugier, D.; Goldman, R. A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J. Antibiot. 1995, 48, 306-310.
32. Escalante, A.; Gattuso, M.; Pérez, P.; Zacchino S. Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J. Nat. Prod. 2008, 71, 1720-1725.
33. Lunde, C.; Kubo, I. Effect of polygodial on the mitochondrial ATPase of Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 2000, 44, 1943-1953. (Pubitemid 30422953)
34. Matsumori, N.; Sawada, Y.; Murata, M. Mycosamine orientation of amphotericin B controlling interaction with ergosterol: Sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge. J. Am. Chem. Soc. 2005, 127, 10667-10675. (Pubitemid 41061440)
35. Gruda, I.; Nadeau, P.; Brajtburg, J. Application of differential spectra in the ultraviolet-visible region to study the formation of amphotericin B-sterol complexes. Biochim. Biophys. Acta 1980, 602, 260-268. (Pubitemid 11216173)